Abstract
In this chapter, carefully selected examples have been elaborated to illustrate how transition state analog inhibitors can be elegantly developed for different types of enzymatic reactions involved in various life processes and therapeutic areas. Every effort has been made to ensure an updated and succinct yet comprehensive coverage of the subject matter.
Publisher
Royal Society of Chemistry